Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets.


Updates from The Motley Fool

Latest updates on Transition Therapeutics from Fool.com.


Stock Performance

View Interactive TTHI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Transition Therapeutics.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): ($1.07)
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Tony F. Cruz, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Transition Therapeutics.

Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers